Delaying antimalarial drug resistance with combination chemotherapy.
about
Epidemiological models for the spread of anti-malarial resistanceA randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand.Mechanisms of drug resistance in colon cancer and its therapeutic strategiesSubstandard/counterfeit antimicrobial drugsMapping the spread of malaria drug resistancePlasmodium falciparum: differential selection of drug resistance alleles in contiguous urban and peri-urban areas of Brazzaville, Republic of CongoPfMDR1: mechanisms of transport modulation by functional polymorphismsSelective inhibitors of protozoan protein N-myristoyltransferases as starting points for tropical disease medicinal chemistry programsMalaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999-2011: an observational studyA database of antimalarial drug resistance.Community perceptions of malaria and malaria treatment behaviour in a rural district of Ghana: implications for artemisinin combination therapy.Adherence to Artesunate-Amodiaquine Therapy for Uncomplicated Malaria in Rural Ghana: A Randomised Trial of Supervised versus Unsupervised Drug AdministrationProspective strategies to delay the evolution of anti-malarial drug resistance: weighing the uncertainty.Cost effectiveness analysis of strategies to combat malaria in developing countries.Artemisinin‐induced dormancy in plasmodium falciparum: duration, recovery rates, and implications in treatment failure.Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations.In vitro and in vivo interactions between miltefosine and other antileishmanial drugsPlasmodium falciparum clearance with artemisinin-based combination therapy (ACT) in patients with glucose-6-phosphate dehydrogenase deficiency in Mali.The global distribution and population at risk of malaria: past, present, and futurePerformance of HRP2-based rapid test in children attending the health centre compared to asymptomatic children in the community.Efficacy and safety of artemisinin combination therapy (ACT) for non-falciparum malaria: a systematic review.Artemether-lumefantrine versus artesunate plus amodiaquine for treating uncomplicated childhood malaria in Nigeria: randomized controlled trial.Plasmodium drug targets outside the genetic control of the parasite.Fosmidomycin, a novel chemotherapeutic agent for malaria.The effect of intermittent preventive treatment on anti-malarial drug resistance spread in areas with population movement.Adverse effect of rifampin on quinine efficacy in uncomplicated falciparum malaria.Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates.Increased pfmdr1 copy number and sequence polymorphisms in Plasmodium falciparum isolates from Sudanese malaria patients treated with artemether-lumefantrine.Malaria policies versus practices, a reality check from Kinshasa, the capital of the Democratic Republic of Congo.History, dynamics, and public health importance of malaria parasite resistance.In vitro and in vivo activity of solithromycin (CEM-101) against Plasmodium speciesSafety evaluation of fixed combination piperaquine plus dihydroartemisinin (Artekin) in Cambodian children and adults with malaria.Therapy of falciparum malaria in sub-saharan Africa: from molecule to policy.Prevalence of K13-propeller gene polymorphisms among Plasmodium falciparum parasites isolated from adult symptomatic patients in northern Uganda.In Vitro Activities of Primaquine-Schizonticide Combinations on Asexual Blood Stages and Gametocytes of Plasmodium falciparumAccuracy of malaria rapid diagnosis test Optimal-IT(®) in Kinshasa, the Democratic Republic of Congo.Delayed Plasmodium falciparum clearance following artesunate-mefloquine combination therapy in Thailand, 1997-2007.In vitro-reduced susceptibility to artemether in P. falciparum and its association with polymorphisms on transporter genesThe changing limits and incidence of malaria in Africa: 1939-2009.Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand.
P2860
Q24805506-A4308260-4B98-4531-AE8E-C29204A20173Q24814579-9C082B40-BAC7-4D03-BB91-7A958B126029Q26738528-2FF8478A-4C38-4A40-AE8F-115CA5F23AF2Q27009319-4EA82359-245B-4794-A735-D8F3797C42A7Q28475191-6A7D2C8C-CBBC-4F6B-9FCD-E0D702B55221Q28476554-E5ED186C-927B-4961-9DBF-C39C1E56B786Q28476753-8F435F68-881D-40F0-BCC2-5F58D82A2E2FQ28482502-638D576D-F4AE-479A-B62B-6040C777C0E4Q28487636-25F5F97C-29DB-4078-B7BA-8E42083BAE7CQ30483123-BE7F6B18-DD25-472E-B30D-0A251D4EDD9AQ33630844-8BB48F71-504E-450D-96A4-5A99BC9A1A39Q33720881-5D9D4249-B657-4BBC-8BE6-0B01E4BAB4BEQ34047599-45009C1E-7C6D-4F03-B7AC-F8C549773778Q34165448-6B040067-ABA5-4A48-8BEE-F7BB2EE08BF4Q34172447-44C11EF2-C68A-44A4-8E1E-038972AF2446Q34198094-66A81AF5-298B-4A90-9602-7B01A602F7CFQ34301638-6F27A123-4A11-4BFF-9C1B-35ADDCDA0EDEQ34398049-3BCC120A-D708-48CD-8DB5-A36302877DE4Q34548302-1EC8BDFD-D087-42B0-937D-A3EDC4943D79Q34591320-C463369D-030D-4AF9-872D-AC583C0DFD9BQ34646141-49045CA1-46DE-4F8C-97AC-F6E952C4AA25Q34666104-8C8AA73A-54BF-433F-B81F-78744500A823Q34678568-B52C4D6A-B392-455E-A2C7-5CFD5D838C58Q34823125-0C0CCBE0-CBDD-4E91-92CA-048CDA6AE31EQ34894294-3E0A1F66-4C34-465A-A6B0-C89CE6A8FE65Q34937320-2C418B04-5DD0-409C-A6B6-BA3A9884A9C4Q35146682-2DB64C29-FBE5-43F0-B74F-932D8685BF56Q35364589-7F6DA6B6-E3E6-4E68-83F1-5DFFC394BC39Q35413341-808F8E56-8715-4AC4-8749-2C2F70AF5633Q35545447-953F955D-E3AD-43C9-A06E-25FC42EB18EEQ35689416-238E3D17-4D78-47BC-9E1B-6D886C6EA964Q35825877-B3C49F70-B3A5-4933-A635-FB53F7731EB9Q35838600-F4B9F345-A79D-4D57-B01A-3412AC7DF1F4Q36108352-89600F7B-B43E-461C-BC2B-6A9996FD1BFDQ36290632-F630C7F2-BAB6-497B-BEA4-C08181807559Q36300267-E0D7EEDF-3566-47B7-A2E0-2CED100C7C33Q36338542-BF5430E5-0EE8-4372-82C0-93CA657E5870Q36376217-B93DE902-6E20-4B0D-A96E-476306E02137Q36463337-8952643A-DEBE-47D5-830F-6CC0DEE2A917Q36482878-8E129FBE-9FDD-456D-9C82-1D0691C40D0C
P2860
Delaying antimalarial drug resistance with combination chemotherapy.
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Delaying antimalarial drug resistance with combination chemotherapy.
@ast
Delaying antimalarial drug resistance with combination chemotherapy.
@en
type
label
Delaying antimalarial drug resistance with combination chemotherapy.
@ast
Delaying antimalarial drug resistance with combination chemotherapy.
@en
prefLabel
Delaying antimalarial drug resistance with combination chemotherapy.
@ast
Delaying antimalarial drug resistance with combination chemotherapy.
@en
P1433
P1476
Delaying antimalarial drug resistance with combination chemotherapy.
@en
P304
P577
1999-09-01T00:00:00Z